Stock viewBusiness Standard
Pharma stocks rally: Aurobindo, Divi's, Glenmark, Symbiotec hit new highs
Positive0
GreyOak summary
The Nifty Pharma index gained 1% to a new high of 27,197.25 driven by strong earnings. Symbiotec Pharmalab surged 20% with 43% revenue growth, while Sail Life Sciences reported 23% revenue growth. Aurobindo Pharma also hit new highs benefiting from INR depreciation.
What it affects
- Symbiotec PharmalabSYMBIOTECPositive 0
Stock zoomed 20% on revenue growth.Rolling sentiment Positive +29
- Divi's LaboratoriesDIVISLABPositive 0
Stock hit new all-time high.Rolling sentiment Positive +80
- Glenmark PharmaceuticalsGLENMARKPositive 0
Stock hit new all-time high.Rolling sentiment Negative -54
Source
Read the original at Business StandardMore Symbiotec Pharmalab news
- Motilal Oswal raises Symbiotec target to Rs 1800Moneycontrol · Company update ·
- Symbiotec Pharma shares hit new high on Q2 resultsBusiness Standard · Results ·